Hologic Medical Device Company Intelligence Report

Date: January 22, 2011
Pages: 42
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H291F59E701EN
Leaflet:

Download PDF Leaflet

Hologic Medical Device Company Intelligence Report
Hologic develops and manufactures medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Through several key acquisitions, the company has increased its revenues from US$288 million in 2005 to almost US$1,680 million in 2010.

Historically, Hologic developed and manufactured products focused on mammography, breast care and osteoporosis assessment. In connection with its transformational merger with Cytyc in October 2007, the company added two significant new operating segments and combined a number of previous operating segments to better align the new resources of the combined company. In July 2008, Hologic also acquired Third Wave Technologies, a company that develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications based on its proprietary Invader chemistry. More recent acquisitions include the August 2010 purchase of Sentinelle Medical, a producer of custom MR coils, patient positioning and magnetic resonance computer-aided detection (MR CAD) solutions, and Interlace Medical along with its MyoSure hysteroscopic tissue removal system, in January 2011.

Hologic operates its business under four reporting segments:
  • Breast Health – produces a portfolio of breast imaging and related products and accessories, including digital and film-based mammography systems (the Selenia full-field digital mammography (FFDM) and Dimensions breast tomosynthesis systems), MRI breast coils, CAD for mammography and MRI, breast biopsy guidance systems, minimally-invasive breast biopsy devices, breast biopsy site markers, breast imaging comfort pads and breast brachytherapy products (MammoSite).
  • Diagnostics – includes the ThinPrep System, which is primarily used in cytology applications, such as cervical cancer screening, the Rapid Fetal Fibronectin Test, which offers clinical benefits for the assessment of the risk of pre-term birth, and molecular diagnostic reagents used for a variety of DNA and RNA analysis applications based on Hologic’s Invador chemistry.
  • GYN Surgical – manufactures the NovaSure endometrial ablation system, which enables physicians to treat women suffering from excessive menstrual bleeding in a minimally-invasive manner, and the Adiana permanent contraception system, which is intended as an alternative to tubal ligation.
  • Skeletal Health – includes QDR X-ray bone densitometers, the Sahara ultrasound-based osteoporosis assessment product and Fluoroscan mini C-arm imaging products.
Headquartered in Bedford, Massachusetts, Hologic employs more than 4,200 employees worldwide. The company’s common stock is listed on the Nasdaq Global Select Market.

This company report provides

Overview
  • Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location
Strategic Focus

Investigates the company’s aims and its areas of focus

Products

Core product areas, key brands, product approvals and launches

Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities
Agreements
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

First Quarter Fiscal 2011 Financial Results
  Breast Health
  Diagnostics
  GYN Surgical
  Skeletal Health
  Sales by Geographic Area
Fiscal 2010 Financial Results
  Breast Health
  Diagnostics
  GYN Surgical
  Skeletal Health
  Sales by Geographic Area
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

PRODUCTS

Breast Health
  Selenia Full Field Digital Mammography System
  Breast Tomosynthesis
  Screen-Film Mammography Systems
  SecurView Workstation
  CAD Systems
  Stereotactic Breast Biopsy Systems
  Breast Biopsy Products
  Breast Brachytherapy
  MammoPad Breast Cushion
  Photoconductor Coatings
  Sentinelle Medical MRI Breast Coils and Workstation
Diagnostics
  ThinPrep System
  Rapid Fetal Fibronectin Test
  HPV Offering and InVitro Diagnostics
GYN Surgical Products
  NovaSure System
  Adiana System
  Tower-Free Hysteroscopy System
  MyoSure Hysteroscopic Tissue Removal System
  GliaSite Radiation Therapy System
Skeletal Health
  QDR X-Ray Bone Densitometers
  Discovery and Explorer Densitometers
  Sahara Clinical Bone Sonometers
  Mini C-arm Imaging

RESEARCH AND DEVELOPMENT

Trials and Studies
  ASBS Registry Trial

MANUFACTURING

AGREEMENTS

Angiotech Pharmaceuticals
SuperSonic Imagine
IsoRay
Exact Sciences
Advanced Image Enhancement (AIE)
Esaote
iCAD
Del Global Technologies
Aloka
InSiteOne
Mammography Reporting System
Agfa-Gevaert
Siemens
  Digital Mammography
  X-ray Bone Densitometers
Varian Medical Systems
Sedecal, Stephanix and Radiologia
Christie Group of Canada

MERGERS AND ACQUISITIONS

Unidentified Company
Interlace Medical
Sentinelle Medical
Third Wave Technologies
Cytyc
BioLucent
Suros Surgical Systems
R2 Technology
AEG Elektrofotografie
Fischer Imaging’s Mammography Business
VH Services
US Assets of Trex Medical
Direct Radiography
Fluoroscan Imaging Systems

MINORITY INVESTMENTS

Combinent BioMedical Systems
Synarc

DIVESTITURES

CT CAD Technology
Gestiva
Mammotest System
Medical Data Management Division

LITIGATION

Conceptus
Ethicon Endo-Surgery
SenoRx
Smith & Nephew

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Hologic - First Quarter Fiscal 2011 Financial Results
Hologic - First Quarter Fiscal 2011 Revenues and Operating Income by Business Sector
Hologic - First Quarter Fiscal 2011 Product Sales by Geographic Area
Hologic - Annual Financial Results, Fiscal Years 2006-2010
Hologic - Annual Revenues and Operating Income by Business Segment, Fiscal Years 2006-2010
Hologic - Annual Product Sales by Geographic Area, Fiscal Years 2006-2010
Hologic – Five-Year Financial Summary
Hologic – Fiscal Year 2011 Guidance
Hologic Employees, Fiscal Years 2006-2010
Hologic - Annual R&D Expenses, Fiscal Years 2006-2010
Hologic - Principal Manufacturing Facilities, January 2011
Agreements Summary
Mergers and Acquisitions Summary

LIST OF CHARTS

Hologic - Annual Revenues and Operating Income, Fiscal Years 2006-2010
Hologic - Annual Product and Service Revenues, Fiscal Years 2006-2010
Hologic - Fiscal 2010 Sales by Geographic Area.
Hologic - Annual Breast Health Product Sales, Fiscal Years 2006-2010
Hologic - Annual Diagnostics Product Sales, Fiscal Years 2008-2010
Hologic - Annual GYN Surgical Product Sales, Fiscal Years 2008-2010
Hologic - Skeletal Health Product Sales, Fiscal Years 2006-2010
Skip to top


Ask Your Question

Hologic Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: